The effect of apatinib combined with chemotherapy or targeted therapy on non‐small cell lung cancer in vitro and vivo

BACKGROUND: The aim of this study was to investigate the feasibility of using a combination of apatinib in the treatment of non‐small cell lung cancer. Apatinib is a tyrosine kinase inhibitor which selectivelyacts on vascular endothelial growth factor receptor 2 (VEGFR‐2) and has shown good efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mingtao, Wang, Xiuxiu, Li, Hui, Xu, Lisheng, Jing, Lijun, Jiang, Peng, Liu, Baoyi, Li, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775003/
https://www.ncbi.nlm.nih.gov/pubmed/31486270
http://dx.doi.org/10.1111/1759-7714.13162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775003/
https://www.ncbi.nlm.nih.gov/pubmed/31486270
http://dx.doi.org/10.1111/1759-7714.13162

Ejemplares similares